因而重组促红细胞生成素对红细胞生成的刺激作用作为一种替代方法引起了人们的关注。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
本文重点讨论了重组人促红细胞生成素的临床应用及其检测。
This paper mainly discussed the clinic applications of rHuEPO and its detecting techniques.
血液透析病人血瘦素与BMI呈正相关，但重组人促红细胞生成素治疗可使两者相关性消失。
Leptin was positively correlated with BMI in HD patients, and EPO therapy can make the relationship disappear.
目的研究重组人促红细胞生成素预处理对缺血性急性肾衰竭的保护作用并探讨其可能的作用机制。
ObjectiveTo investigate the effect of preconditioning with recombinant human erythropoietin (rhEPO) on an in vivo rat model of ischemic acute renal failure and the possible mechanisms.
目的研究重组人促红细胞生成素预处理对缺血性急性肾衰竭的保护作用并探讨其可能的作用机制。
ObjectiveTo investigate the effect of preconditioning with recombinant human erythropoietin (rhEPO) on an in vivo rat model of ischemic acute renal failure and the possible mechanisms.
应用推荐